Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Voyager Therapeutics, Inc. (VYGR) had Weighted-Average Shares Outstanding (Basic) of 60.55M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$3.17M |
|
$-24.47M |
|
-- |
|
$3.17M |
|
$29.56M |
|
$-26.39M |
|
$1.94M |
|
$-24.45M |
|
$-24.45M |
|
$-24.47M |
|
$-24.47M |
|
$-24.47M |
|
$-24.47M |
|
$-26.39M |
|
$-25.73M |
|
|
Weighted-Average Shares Outstanding (Basic) |
60.55M |
60.55M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$125.23M |
|
$11.19M |
|
$72.53M |
|
$197.75M |
|
$16.68M |
|
-- |
|
$26.69M |
|
$43.38M |
|
$154.38M |
|
$154.38M |
|
$154.38M |
|
61.27M |
|
| Cash Flow Statement Financials | |
$-59.26M |
|
$23.49M |
|
$6.24M |
|
$68.04M |
|
$38.51M |
|
$-29.53M |
|
$4.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-833.87% |
|
-833.87% |
|
-- |
|
-772.61% |
|
-773.24% |
|
$-59.27M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.00 |
|
89.69 |
|
-15.85% |
|
-15.85% |
|
-12.38% |
|
-15.85% |
|
$2.52 |
|
$-0.98 |
|
$-0.98 |
|